← Eichor
Condition: Stage I Colon Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage I Colon Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NA · 9 location(s) · University of Aarhus · NCT06614647
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Se
Phase 1 · 3 location(s) · Molecure S.A. · NCT05759923
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 29 location(s) · Novartis Pharmaceuticals · NCT06562192
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorect
Phase 1/Phase 2 · 1 location(s) · BeyondBio Inc. · NCT05093907
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
NA · 1 location(s) · University of South Florida · NCT07419490
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Phase 1 · 2 location(s) · Hefei TG ImmunoPharma Co., Ltd. · NCT05746897
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
Phase N/A · 1 location(s) · Singlera Genomics Inc. · NCT05536089
Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointes
Phase 1/Phase 2 · 2 location(s) · Anwaar Saeed · NCT03539822
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT07417488
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT06867822
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survi
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06746012
A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
Phase 1/Phase 2 · 2 location(s) · Neogap Therapeutics AB · NCT05908643
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Weijia Fang, MD · NCT06821048
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Phase 1 · 35 location(s) · EMD Serono Research & Development Institute, Inc. · NCT05464030
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Phase N/A · 1 location(s) · Case Comprehensive Cancer Center · NCT04624555
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT06882746
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Phase 1/Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT03965234
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 79 location(s) · Artios Pharma Ltd · NCT04657068
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169
IDOV-Immune for Advanced Solid Tumors
Phase 1 · 5 location(s) · ViroMissile, Inc. · NCT06910657
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
EARLY_Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT02172651
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/Phase 2 · 5 location(s) · Cancer Research UK · NCT05944237
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Phase N/A · 10 location(s) · M.D. Anderson Cancer Center · NCT04739072
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · 84 location(s) · Hoffmann-La Roche · NCT04929223
Partial Liver Segment 2/3 Transplantation Study
Phase 1/Phase 2 · 1 location(s) · Oslo University Hospital · NCT02215889
Virtual Rehabilitation for Cancer Survivors
NA · 1 location(s) · University Health Network, Toronto · NCT05898789
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.